FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to an artificial nucleic acid molecule. Synergetic effect provided by the presence of 3'-UTR of an albumin gene and the 3-untranslated region of the mRNA, placed in the secondary stem-loop sequence, in the structure of the artificial nucleic acid sequence, allows to increase the stability and prolong the expression of the encoded protein.
EFFECT: invention further relates to the use of such an artificial nucleic acid molecule, encoding therapeutic peptides or proteins in medicine for gene therapy and/or genetic vaccination.
63 cl, 23 dwg, 5 ex, 14 tbl
Authors
Dates
2018-04-19—Published
2013-03-27—Filed